Dan Huang
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 6
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 5
- Pharmaceutical Science top 10%
-
- RNA Interference and Gene Delivery 4
- Circular RNAs in diseases 4
- Retinoids in leukemia and cellular processes 2
-
- Biomarkers in Disease Mechanisms 2
-
- Metabolism and Genetic Disorders 2
- Co-authors
- Ting ZhongXin YaoXuan ZhangWei RenShuang ZhangQiang ZhangChao WangYang Zhao
- Journals
- Journal of the American Chemical Society (1 paper)PLoS ONE (1 paper)Scientific Reports (2 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Dan Huang
39 papers receiving 782 citations
Peers
Comparison fields: 5 of 90
- Biomaterials 302
- Cancer Research 131
- Pharmaceutical Science 41
- Molecular Biology 434
- Drug Discovery 1
Countries citing papers authored by Dan Huang
This map shows the geographic impact of Dan Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Huang more than expected).
Fields of papers citing papers by Dan Huang
This network shows the impact of papers produced by Dan Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Huang. The network helps show where Dan Huang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dan Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 13 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 12 | |
| 8 | 2022 | 12 | |
| 9 | 2022 | 19 | |
| 10 | 2022 | 8 | |
| 11 | 2019 | 0 | |
| 12 | 2019 | 14 | |
| 13 | 2018 | 14 | |
| 14 | 2017 | 16 | |
| 15 | 2016 | 11 | |
| 16 | 2016 | 63 | |
| 17 | 2015 | 8 | |
| 18 | 2015 | 6 | |
| 19 | 2013 | 14 | |
| 20 | 2009 | 5 |
About Dan Huang
Dan Huang is a scholar working on Biomaterials, Molecular Medicine and Cancer Research, having authored 42 papers that have together received 794 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (6 papers), Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (5 papers), RNA Interference and Gene Delivery (4 papers), Circular RNAs in diseases (4 papers), Biomarkers in Disease Mechanisms (2 papers), Metabolism and Genetic Disorders (2 papers) and Retinoids in leukemia and cellular processes (2 papers). The work is most often cited by research in Biomaterials (302 citations), Cancer Research (131 citations) and Pharmaceutical Science (41 citations). Dan Huang has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Ting Zhong, Xin Yao, Xuan Zhang, Wei Ren, Shuang Zhang, Qiang Zhang, Chao Wang, Yang Zhao, Yang Guo and Xiao-Chuan Duan. Their work appears in journals such as Journal of the American Chemical Society, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.